/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

X

X. Pivot

Institut de Cancérologie Strasbourg(FR)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

21

Papers

513

Citations

7

h-index

7

i10-index

X. Pivot is an academic researcher from Institut de Cancérologie Strasbourg. The author has contributed to research in topics: Global Cancer Incidence and Screening & Breast Cancer Treatment Studies & Head and Neck Cancer Studies. The author has an h-index of 7, co-authored 18 publications.

Research Topics

Global Cancer Incidence and Screening Breast Cancer Treatment Studies Head and Neck Cancer Studies HER2/EGFR in Cancer Research Cancer Treatment and Pharmacology

Papers by this author

works

6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial

2013 · The Lancet Oncology · 337 citations

https://doi.org/10.1016/s1470-2045(13)70225-0

X. Pivot Gilles Romieu Marc Debled Jean‐Yves Pierga

Research topics

topics

Global Cancer Incidence and Screening

Breast Cancer Treatment Studies

Head and Neck Cancer Studies

HER2/EGFR in Cancer Research

Cancer Treatment and Pharmacology

Chat about Author

Papers

Chat

Click to start Chat